Boyapati A, et al. High Baseline Serum IL-6 Identifies a Subgroup of Rheumatoid Arthritis Patients with Rapid Joint Damage and Clinical Progression and Predicts Increased Sarilumab Treatment Response. ACR 2018, abstract L08.
Voorkeuren van patiënten met arthritis psoriatica bij kiezen biological
nov 2021 | Arthritis psoriatica